How-pharma-can-overcome-inflation: Difference between revisions

Article published by [[Other sources |Pharma manufacturing]] and reviewed by Nikolay Sidelnikov
No edit summary
No edit summary
Line 22: Line 22:
The article [https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/11414874/how-pharma-can-overcome-inflation How pharma can overcome inflation] was published by Pharma manufacturing in 2022. It describes the potential effect of D2C business model that according to the article may reel in excess costs and increase user adoption without sacrificing margins — while still passing on the savings to patients.
The article [https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/11414874/how-pharma-can-overcome-inflation How pharma can overcome inflation] was published by Pharma manufacturing in 2022. It describes the potential effect of D2C business model that according to the article may reel in excess costs and increase user adoption without sacrificing margins — while still passing on the savings to patients.


 
The author lists the following potential benefits: ...


Full article: [https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/11414874/how-pharma-can-overcome-inflation How pharma can overcome inflation]
Full article: [https://www.pharmamanufacturing.com/quality-risk/supply-chain/article/11414874/how-pharma-can-overcome-inflation How pharma can overcome inflation]

Revision as of 12:10, 10 April 2024

How pharma can overcome inflation (with abstract)
Published By[[Pharma manufacturing]]
Publish DateSept. 14, 2022
AuthorsCathy Tie
Topics B2B eCommerce in Pharma
Statistics
Article Sizewords
DiagramsNo
Downloadable VersionNo
Reviewers
Page OwnerNikolay Sidelnikov
Summary AuthorNikolay Sidelnikov


Abstract

The article How pharma can overcome inflation was published by Pharma manufacturing in 2022. It describes the potential effect of D2C business model that according to the article may reel in excess costs and increase user adoption without sacrificing margins — while still passing on the savings to patients.

The author lists the following potential benefits: ...

Full article: How pharma can overcome inflation


Subscribe to B2B Experts Digest

Contribute to B2B Experts Community